SEC Form 4 research
| Issuer | SUPERNUS PHARMACEUTICALS INC |
|---|---|
| Tickers | SUPN |
| Reporting owners | 36 |
| Officers and directors | 22 |
| Last public filing | 2026-08-01 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-07-31 | 2026-07-29 | Rubin Jonathan | A | 750 | $0 | Not reported |
| 2026-07-31 | 2026-07-29 | Mottola Frank | A | 1,650 | $0 | Not reported |
| 2026-07-31 | 2026-07-29 | Khattar Jack A. | A | 29,849 | $0 | Not reported |
| 2026-07-31 | 2026-07-29 | Bhatt Padmanabh P. | A | 2,500 | $0 | Not reported |
| 2026-07-31 | 2026-07-29 | DEC TIMOTHY C | A | 1,250 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.